GL1X · GenesisL1 explorer

Research workbench

Leishmania major N-myristoyltransferase with bound myristoyl-CoA and inhibitor

Analyse Leishmania major N-myristoyltransferase with bound myristoyl-CoA and inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6EU5
Type
protein
Length
411 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycylpeptide N-tetradecanoyltransferase
EC
2.3.1.97
UniProt
Q4Q5S8
Ligands
MYA, BXN
Pockets
2 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 32% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycylpeptide N-tetradecanoyltransferase (EC 2.3.1.97)protein41132% helix, 28% strandQ4Q5S8

Ligands and binding sites

  • MYA · Tetradecanoyl-coa · ligand · chains A
  • BXN · 4-[3-[(8~{A}~{R})-3,4,6,7,8,8~{A}-hexahydro-1~{H}-pyrrolo[1,2-a]pyrazin-2-yl]propyl]-2,6-bis(chloranyl)-~{N}-methyl-~{N}-(1,3,5-trimethylpyrazol-4-yl) benzenesulfonamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19870.790.8191MYA, BXN
21120.410.7626empty

Compared structures

  • 6EU5 · Leishmania major N-myristoyltransferase with bound myristoyl-CoA and inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.